ATE165868T1 - Verfahren zur enzymatischen herstellung geschützter und ungeschützter di- und oligopeptide in wässrigen lösungen - Google Patents

Verfahren zur enzymatischen herstellung geschützter und ungeschützter di- und oligopeptide in wässrigen lösungen

Info

Publication number
ATE165868T1
ATE165868T1 AT92101000T AT92101000T ATE165868T1 AT E165868 T1 ATE165868 T1 AT E165868T1 AT 92101000 T AT92101000 T AT 92101000T AT 92101000 T AT92101000 T AT 92101000T AT E165868 T1 ATE165868 T1 AT E165868T1
Authority
AT
Austria
Prior art keywords
amino acid
oligopeptide
alpha
protected
oligopeptides
Prior art date
Application number
AT92101000T
Other languages
German (de)
English (en)
Inventor
Andreas Fischer
Alexander Schwarz
Christian Wandrey
Guenter Knaup
Andreas Bommarius
Karl-Heinz Drauz
Original Assignee
Forschungszentrum Juelich Gmbh
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forschungszentrum Juelich Gmbh, Degussa filed Critical Forschungszentrum Juelich Gmbh
Application granted granted Critical
Publication of ATE165868T1 publication Critical patent/ATE165868T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT92101000T 1991-01-23 1992-01-22 Verfahren zur enzymatischen herstellung geschützter und ungeschützter di- und oligopeptide in wässrigen lösungen ATE165868T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4101895A DE4101895C1 (enExample) 1991-01-23 1991-01-23

Publications (1)

Publication Number Publication Date
ATE165868T1 true ATE165868T1 (de) 1998-05-15

Family

ID=6423542

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92101000T ATE165868T1 (de) 1991-01-23 1992-01-22 Verfahren zur enzymatischen herstellung geschützter und ungeschützter di- und oligopeptide in wässrigen lösungen

Country Status (5)

Country Link
US (1) US5304470A (enExample)
EP (1) EP0496373B1 (enExample)
JP (1) JP3447066B2 (enExample)
AT (1) ATE165868T1 (enExample)
DE (2) DE4101895C1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW306932B (enExample) * 1993-08-27 1997-06-01 Holland Sweetener Co
DE4423724A1 (de) * 1994-07-08 1996-01-11 Degussa Kinetisch kontrolliertes Verfahren zur enzymatischen Herstellung von Peptiden
ATE309264T1 (de) 1997-04-18 2005-11-15 Cephalon Inc Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
WO2001032906A2 (en) * 1999-10-29 2001-05-10 Novus International, Inc. Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids
US6939693B2 (en) * 1999-10-29 2005-09-06 Novus International, Inc. Enantioselective oligomerization of α-hydroxy carboxylic acids and α-amino acids
US7723303B2 (en) * 2000-08-24 2010-05-25 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7199102B2 (en) * 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US20040052928A1 (en) * 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US7781396B2 (en) * 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
US7491699B2 (en) * 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
WO2004060791A1 (en) 2003-01-07 2004-07-22 Ramot At Tel Aviv University Ltd. Peptide nanostructures encapsulating a foreign material and method of manufacturing same
CN101415724B (zh) * 2003-06-30 2015-12-02 特拉维夫大学未来科技开发有限公司 肽、抗肽抗体以及用它们来诊断和治疗淀粉样蛋白相关疾病的方法
CA2540407A1 (en) * 2003-09-25 2005-03-31 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
WO2005031362A2 (en) * 2003-10-02 2005-04-07 Ramot At Tel Aviv University Ltd. Novel antibacterial agents and methods of identifying and utilizing same
WO2006006172A2 (en) * 2004-07-15 2006-01-19 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
US8568637B2 (en) * 2004-08-02 2013-10-29 Ramot At Tel-Aviv University Ltd. Method of forming a fiber made of peptide nanostructures
ATE539745T1 (de) * 2004-08-19 2012-01-15 Univ Tel Aviv Future Tech Dev Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen
WO2006027780A2 (en) 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
CA2580501A1 (en) * 2004-09-16 2006-03-30 The Regents Of The University Of California G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
NZ555826A (en) 2004-12-06 2009-11-27 Univ California Methods for improving the structure and function of arterioles
US20080293639A1 (en) * 2005-04-29 2008-11-27 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US10004828B2 (en) * 2005-10-11 2018-06-26 Romat at Tel-Aviv University Ltd. Self-assembled Fmoc-ff hydrogels
US7879212B2 (en) * 2005-11-03 2011-02-01 Ramot At Tel-Aviv University Ltd. Peptide nanostructure-coated electrodes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH618842A5 (en) * 1975-09-30 1980-08-29 Ciba Geigy Ag Pesticides
DE3733198A1 (de) * 1987-10-01 1989-04-13 Kernforschungsanlage Juelich Enzymatisches verfahren zur herstellung von dipeptiden

Also Published As

Publication number Publication date
JP3447066B2 (ja) 2003-09-16
DE59209313D1 (de) 1998-06-10
US5304470A (en) 1994-04-19
EP0496373A1 (de) 1992-07-29
JPH0698788A (ja) 1994-04-12
DE4101895C1 (enExample) 1991-12-05
EP0496373B1 (de) 1998-05-06

Similar Documents

Publication Publication Date Title
ATE165868T1 (de) Verfahren zur enzymatischen herstellung geschützter und ungeschützter di- und oligopeptide in wässrigen lösungen
McDonald et al. On the substrate specificity of cathepsins B1 and B2 including a new fluorogenic substrate for cathepsin B1
US6034066A (en) Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases
RO80806A (ro) Procedeu pentru obtinerea enzimatica a peptidelor
ATE377006T1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
ATE81854T1 (de) Aminoluciferine, verfahren zu deren herstellung und ihre verwendung.
ATE96175T1 (de) Verfahren zur enzymatischen herstellung von dipeptiden.
DE68913880D1 (de) Verfahren zur enzymatischen Herstellung von Dipeptiden.
KR20110088519A (ko) 효소적 활성화 및 커플링을 이용한 펩티드 합성
FR2546164B1 (fr) Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
JPS5524147A (en) Peptide derivative
EP0149594A2 (en) Enzymatic coupling of n-formyl amino acids and/or peptide residues
Oda et al. Purification and properties of a proteinaceous metallo-proteinase inhibitor from Streptomyces nigrescens TK-23
GB1000896A (en) Novel peptide derivatives and a process for the manufacture thereof
Swanson et al. Mammalian lens dipeptidyl aminopeptidase III
Oka et al. Comparative specificity of microbial acid proteinases for synthetic peptides: II. Effect of secondary interaction
Krix et al. Protease-catalyzed synthesis of new hydrophobic dipeptides containing non-proteinogenic amino acids
DE68923625T2 (de) Enzymatischer Prozess zur Herstellung immunomodulatorischer Pentapeptide und Intermediate zu deren Herstellung.
Natchev Total synthesis and enzyme-substrate interaction of D-, DL-, and L-phosphinotricine,‘bialaphos’(SF-1293) and its cyclic analogues
Lee et al. Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway
CA1059938A (en) Process for producing a peptide
Cohen et al. Carboxamidomethyl esters as reactive substrates for alpha-chymotrypsin. Orientational effects of hydrogen-bonding interactions.
JPH01199595A (ja) ジペプチドの酵素的製法
JPS62242698A (ja) 発色性ペプチドおよびそれらの製造方法
CA2075771A1 (en) Enzymatic synthesis of renin inhibitors

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee